Suzanne M Gilboa

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010
    Suzanne M Gilboa
    From Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities S M G, O J D, J E K, M E O, T R C, and Office of the Associate Director of Policy J E K, Centers for Disease Control and Prevention, Atlanta, GA Carter Consulting, Atlanta, GA O J D Children s Healthcare of Atlanta, Emory University School of Medicine, GA M E O University of South Florida, Tampa W N N, P X University of Arkansas for Medical Sciences and Arkansas Children s Hospital Research Institute, Little Rock W N N University of Mississippi Medical Center, Jackson A C Children s Hospital Boston, MA K J and McGill Adult Unit for Congenital Heart Disease, Montreal, QC, Québec A J M
    Circulation 134:101-9. 2016
  2. pmc Antihistamines and birth defects: a systematic review of the literature
    Suzanne M Gilboa
    Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Birth Defects and Developmental Disabilities, Mail Stop E 86, 1600 Clifton Road, Atlanta, GA 30333, USA, 1 404 498 4425
    Expert Opin Drug Saf 13:1667-98. 2014
  3. pmc Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Occup Environ Med 69:628-35. 2012
  4. ncbi Comparison of residential geocoding methods in population-based study of air quality and birth defects
    Suzanne M Gilboa
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Environ Res 101:256-62. 2006
  5. doi Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Am J Med Genet C Semin Med Genet 157:234-46. 2011
  6. pmc Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E 86, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Circulation 122:2254-63. 2010
  7. doi Association between prepregnancy body mass index and congenital heart defects
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 202:51.e1-51.e10. 2010
  8. pmc Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects
    Adolfo Correa
    Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 206:218.e1-13. 2012
  9. doi Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005
    Kari Bjornard
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Birth Defects Res A Clin Mol Teratol 97:87-94. 2013
  10. pmc Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005
    James E Kucik
    Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA 30333, USA
    Public Health Rep 127:52-61. 2012

Detail Information

Publications36

  1. pmc Congenital Heart Defects in the United States: Estimating the Magnitude of the Affected Population in 2010
    Suzanne M Gilboa
    From Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities S M G, O J D, J E K, M E O, T R C, and Office of the Associate Director of Policy J E K, Centers for Disease Control and Prevention, Atlanta, GA Carter Consulting, Atlanta, GA O J D Children s Healthcare of Atlanta, Emory University School of Medicine, GA M E O University of South Florida, Tampa W N N, P X University of Arkansas for Medical Sciences and Arkansas Children s Hospital Research Institute, Little Rock W N N University of Mississippi Medical Center, Jackson A C Children s Hospital Boston, MA K J and McGill Adult Unit for Congenital Heart Disease, Montreal, QC, Québec A J M
    Circulation 134:101-9. 2016
    ..However, there are no current empirical data documenting the number of people living with CHDs in the United States. Our aim was to estimate the CHD prevalence across all age groups in the United States in the year 2010...
  2. pmc Antihistamines and birth defects: a systematic review of the literature
    Suzanne M Gilboa
    Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Division of Birth Defects and Developmental Disabilities, Mail Stop E 86, 1600 Clifton Road, Atlanta, GA 30333, USA, 1 404 498 4425
    Expert Opin Drug Saf 13:1667-98. 2014
    ..Approximately 10 - 15% of women reportedly take an antihistamine during pregnancy for the relief of nausea and vomiting, allergy and asthma symptoms, or indigestion. Antihistamines include histamine H1-receptor and H2-receptor antagonists...
  3. pmc Association between maternal occupational exposure to organic solvents and congenital heart defects, National Birth Defects Prevention Study, 1997-2002
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Occup Environ Med 69:628-35. 2012
    ....
  4. ncbi Comparison of residential geocoding methods in population-based study of air quality and birth defects
    Suzanne M Gilboa
    Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    Environ Res 101:256-62. 2006
    ..Incomplete geocoding may have resulted in a selection bias because of the under-representation of Latinas in our study population...
  5. doi Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA
    Am J Med Genet C Semin Med Genet 157:234-46. 2011
    ..This modeling approach could be extended to other medications to estimate the impact of translating pharmacoepidemiologic data to evidence-based prenatal care practice...
  6. pmc Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E 86, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Circulation 122:2254-63. 2010
    ..There is little population-based information on CHD mortality trends and patterns among older children and adults...
  7. doi Association between prepregnancy body mass index and congenital heart defects
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 202:51.e1-51.e10. 2010
    ..The purpose of this study was to examine associations between prepregnancy body mass index (BMI) and congenital heart defects (CHDs)...
  8. pmc Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects
    Adolfo Correa
    Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 206:218.e1-13. 2012
    ..The purpose of this study was to examine the risk of birth defects in relation to diabetes mellitus and the lack of use of periconceptional vitamins or supplements that contain folic acid...
  9. doi Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005
    Kari Bjornard
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Birth Defects Res A Clin Mol Teratol 97:87-94. 2013
    ..We evaluated temporal and racial/ethnic trends in the birth prevalence of CHDs in metropolitan Atlanta from 1978 to 2005...
  10. pmc Racial/ethnic variations in the prevalence of selected major birth defects, metropolitan Atlanta, 1994-2005
    James E Kucik
    Centers for Disease Control and Prevention, National Center on Birth Defects and Developmental Disabilities, Atlanta, GA 30333, USA
    Public Health Rep 127:52-61. 2012
    ..Documenting the variation in prevalence of birth defects among racial/ethnic subpopulations is critical for assessing possible variations in diagnosis, case ascertainment, or risk factors among such groups...
  11. pmc Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects
    Sarah C Tinker
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention CDC, Atlanta, Georgia
    Birth Defects Res A Clin Mol Teratol 97:649-57. 2013
    ..FA fortification of corn masa flour (CMF) is a policy-level intervention for NTD prevention; however, the impact on NTD prevalence has not been estimated...
  12. pmc Diabetes mellitus and birth defects
    Adolfo Correa
    Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 199:237.e1-9. 2008
    ..The purpose of this study was to examine associations between diabetes mellitus and 39 birth defects...
  13. ncbi Characteristics that predict locating and interviewing mothers identified by a state birth defects registry and vital records
    Suzanne M Gilboa
    Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Birth Defects Res A Clin Mol Teratol 76:60-5. 2006
    ..State vital records are often used to select population-based controls in record-linkage studies of birth defects. However, locating and contacting individuals based on these data sources to collect additional data can be a challenge...
  14. pmc Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk
    Phoebe G Thorpe
    Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pharmacoepidemiol Drug Saf 22:1013-8. 2013
    ..To determine which medications are most commonly used by women in the first trimester of pregnancy and identify the critical gaps in information about fetal risk for those medications...
  15. pmc Use of topiramate in pregnancy and risk of oral clefts
    Andrea V Margulis
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Obstet Gynecol 207:405.e1-7. 2012
    ..The objective of this study was to evaluate the association between the use of monotherapy topiramate in pregnancy and cleft lip with or without cleft palate (CL/P) in the offspring...
  16. pmc Racial/ethnic differences in infant mortality attributable to birth defects by gestational age
    Cheryl S Broussard
    Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Pediatrics 130:e518-27. 2012
    ..Previous reports have highlighted black-white differences in overall infant mortality and infant mortality attributable to birth defects (IMBD). We evaluated the impact of gestational age on US racial/ethnic differences in IMBD...
  17. doi Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study
    Clinton J Alverson
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mail Stop E 86, Atlanta, GA 30333, USA
    Pediatrics 127:e647-53. 2011
    ..We investigated associations between maternal cigarette smoking during the first trimester and the risk of congenital heart defects (CHDs) among the infants...
  18. pmc Proportion of selected congenital heart defects attributable to recognized risk factors
    Regina M Simeone
    Division of Congenital and Developmental Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA Electronic address
    Ann Epidemiol 26:838-845. 2016
    ..To assess the contribution of multiple risk factors for two congenital heart defects-hypoplastic left heart syndrome (HLHS) and tetralogy of Fallot (TOF)...
  19. pmc The National Birth Defects Prevention Study: A review of the methods
    Jennita Reefhuis
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
    Birth Defects Res A Clin Mol Teratol 103:656-69. 2015
    ..The National Birth Defects Prevention Study (NBDPS) is a large population-based multicenter case-control study of major birth defects in the United States...
  20. pmc Prenatal diagnosis of nonsyndromic congenital heart defects
    Elizabeth C Ailes
    National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, GA, USA Epidemic Intelligence Service, Office of Surveillance, Epidemiology and Laboratory Services, CDC, Atlanta, GA, USA
    Prenat Diagn 34:214-22. 2014
    ..Congenital heart defects (CHDs) occur in nearly 1% of live births. We sought to assess factors associated with prenatal CHD diagnosis in the National Birth Defects Prevention Study (NBDPS)...
  21. pmc Use of antihistamine medications during early pregnancy and isolated major malformations
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
    Birth Defects Res A Clin Mol Teratol 85:137-50. 2009
    ..There is little evidence that they have teratogenic effects, but there are knowledge gaps with respect to newer products, as well as the relationship between specific antihistamines and specific birth defects...
  22. pmc Late detection of critical congenital heart disease among US infants: estimation of the potential impact of proposed universal screening using pulse oximetry
    Cora Peterson
    Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia2currently affiliated with National Center for Injury Prevention and Con
    JAMA Pediatr 168:361-70. 2014
    ..Limited previous research is directly applicable to the question of how many US infants with CCHD might be identified through screening...
  23. pmc Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011
    Elizabeth C Ailes
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
    Birth Defects Res A Clin Mol Teratol 106:940-949. 2016
    ..To control for potential confounding by indication, we examined associations between antibiotic use and birth defects, among women reporting urinary tract infections (UTIs)...
  24. pmc Maternal intake of vitamin E and birth defects, national birth defects prevention study, 1997 to 2005
    Suzanne M Gilboa
    Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
    Birth Defects Res A Clin Mol Teratol 100:647-57. 2014
    ..To explore this association further, we investigated the association between total daily vitamin E intake and selected birth defects...
  25. doi Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program
    Janet D Cragan
    Division of Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Birth Defects Res A Clin Mol Teratol 85:20-9. 2009
    ..Advances in prenatal diagnosis have led to changes in the management of pregnancies affected with birth defects. These changes pose unique challenges for birth defects monitoring programs which use hospital-based sources...
  26. pmc Limitations, depressive symptoms, and quality of life among a population-based sample of young adults with congenital heart defects
    Sherry L Farr
    Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Birth Defects Res A Clin Mol Teratol 106:580-6. 2016
    ..Little population-based data exist on limitations and health-related quality of life (HRQoL) in adults with congenital heart defects (CHD)...
  27. pmc Estimated number of infants detected and missed by critical congenital heart defect screening
    Elizabeth C Ailes
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
    Pediatrics 135:1000-8. 2015
    ..Our objective was to estimate the number of infants with nonsyndromic CCHDs in the United States likely to be detected (true positives) and missed (false negatives) through universal newborn CCHD screening...
  28. pmc Evaluation of an active surveillance system for stillbirths in metropolitan Atlanta
    Alejandro Azofeifa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Registry Manag 39:13-8, quiz 36. 2012
    ..This pilot project was evaluated using CDC's current guidelines for evaluating surveillance systems...
  29. pmc Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006
    Sarah C Tinker
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Mail Stop E 86, 1600 Clifton Road, Atlanta, GA, 30333, USA
    Matern Child Health J 19:1097-106. 2015
    ..Given the potential impact of medications on the developing fetus, our data underscore the importance of understanding the safety of these medications during pregnancy...
  30. doi Use of spline regression in an analysis of maternal prepregnancy body mass index and adverse birth outcomes: does it tell us more than we already know?
    Suzanne M Gilboa
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Ann Epidemiol 18:196-205. 2008
    ..It is unclear whether further insight into these associations can be gained from spline regression...
  31. doi Estimating the Number of Pregnant Women Infected With Zika Virus and Expected Infants With Microcephaly Following the Zika Virus Outbreak in Puerto Rico, 2016
    Sascha R Ellington
    Centers for Disease Control and Prevention, Atlanta, Georgia2University of Georgia, Athens
    JAMA Pediatr 170:940-945. 2016
    ..Zika virus (ZIKV) infection during pregnancy is a cause of congenital microcephaly and severe fetal brain defects, and it has been associated with other adverse pregnancy and birth outcomes...
  32. doi Maternal exposure to ozone and PM2.5 and the prevalence of orofacial clefts in four U.S. states
    Ying Zhou
    Environmental Health Tracking Branch, Division of Environmental Hazards and Health Effects, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA Electronic address
    Environ Res 153:35-40. 2016
    ..5µm (PM2.5) and ozone during early gestation was associated with a higher prevalence of orofacial clefts...
  33. pmc Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants
    Elizabeth C Ailes
    National Center on Birth Defects and Developmental Disabilities, CDC, Atlanta, Georgia
    Birth Defects Res A Clin Mol Teratol 106:927-934. 2016
    ..Our objective was to identify pregnant women, their pregnancy outcomes, and date of their last menstrual period (LMP), and to estimate antidepressant dispensations in pregnancy...
  34. pmc Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States
    Cora Peterson
    National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention CDC, Atlanta, GA Electronic address
    Am J Obstet Gynecol 212:74.e1-9. 2015
    ..We aimed to estimate the preconception care (PCC)-preventable health and cost burden of adverse birth outcomes associated with diagnosed and undiagnosed pregestational diabetes mellitus (PGDM) in the United States...
  35. pmc Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the national birth defects prevention study
    Jeanette A Stingone
    Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Environ Health Perspect 122:863-72. 2014
    ..Epidemiologic literature suggests that exposure to air pollutants is associated with fetal development...
  36. ncbi Reporting birth defects surveillance data 1968-2003
    Adolfo Correa
    Birth Defects Res A Clin Mol Teratol 79:65-186. 2007